Direct AMPK activator Poxel/DeuteRx

N/A

Report date: 2025/03/19 09:02:40
NME

Base Information

Drug NameDirect AMPK activator Poxel/DeuteRx
Drug Alias NameMPC inhibitor (Poxel/DeuteRx)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activatorsMitochondrial pyruvate carrier inhibitors
TargetsAMP-activated protein kinasesMitochondrial pyruvate carrier
Therapy Area/IndicationsMetabolic DiseasesAdrenoleukodystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPoxel Sa
China Registration ClassN/A

Develop Information

Active CompaniesDeuterxPoxel Sa
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesAdrenoleukodystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A